http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9713350-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
filingDate 1997-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6ff2ba41694a1afb732421d68d51ada
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d0c18feb63d970deec3e29f841afb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb1bf5bdec1d00bf094b27f0f5bc7e41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a4f78a5d2ac52b131b667b49c30b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d1875c4689cd217b3f52f4b6f825e05
publicationDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9713350-A
titleOfInvention Cephalosporin derivatives
abstract "CEPHALOSPORIN DERIVATIVES". They are provided with cephe represented by the general formula (I) in which Q is an optionally substituted pyridinium group attached to the sulfur atom via a ring carbon atom; X is halogen; Y is hydrogen or halogen; L ^ 1 ^ is a furan group, a thiophene group, a C ~ 2 ~ -10 ~ alkyl group, or a C ~ 2-10 ~ alkyl group interrupted with one or more groups independently selected from vinyl, S, SO, SO ~ 2 ~, SO ~ 2 ~ NH (IIa), (IIb); n is 0 or 1; A is CO ~ 2 ~ H, PO ~ 3 ~ H ~ 2 ~, SOP ~ 3 ~ H, or tetrazole; and R ^ 1 ^ is hydrogen or a carboxyl protecting group; and pharmaceutically acceptable salts and / or prodrugs thereof. Derivatives are gram-positive antibacterial agents, especially useful in the treatment of diseases caused by methicillin-resistant Staphylococus aureus (MRSA).
priorityDate 1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414392184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414305203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4989215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8030

Total number of triples: 37.